ENTO
Entero Therapeutics
ENTO
ENTO
4 hedge funds and large institutions have $2.04M invested in Entero Therapeutics in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PA
1
Perceptive Advisors
New York
|
$1.08M |
| 2 |
SM
2
Sabby Management
Miami Beach,
Florida
|
$564K |
| 3 |
PCM
3
Parsons Capital Management
Providence,
Rhode Island
|
$397K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$3K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $1.08M | 227,272 | +227,272 | New |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $564K | 118,993 | +118,993 | New |
|
|
PCM
3
Parsons Capital Management
Providence,
Rhode Island
| $397K | 83,818 | +83,818 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $3K | 617 | +617 | New |
|